FSSNX | GQSCX | FSSNX / GQSCX | |
Total Expense Ratio | 0.03 | 0.85 | 3% |
Annual Report Gross Expense Ratio | 0.03 | 3.65 | 1% |
Fund Existence | 14 years | 8 years | - |
Gain YTD | 8.598 | 3.896 | 221% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 27.7B | 2.28M | 1,217,582% |
Annual Yield % from dividends | 0.84 | 0.19 | 441% |
Returns for 1 year | 11.52 | -5.70 | -202% |
Returns for 3 years | 39.83 | 21.02 | 189% |
Returns for 5 years | 61.41 | 57.62 | 107% |
Returns for 10 years | 103.24 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DFAI | 36.55 | 0.25 | +0.69% |
Dimensional International Cr Eq Mkt ETF | |||
MMCA | 21.77 | 0.03 | +0.14% |
NYLI MacKay California Muni Intmdt ETF | |||
FLIA | 20.52 | 0.01 | +0.07% |
Franklin International Aggregate Bd ETF | |||
XPH | 46.00 | -0.50 | -1.08% |
SPDR® S&P Pharmaceuticals ETF | |||
ETH | 42.32 | -1.70 | -3.86% |
Grayscale Ethereum Mini Trust ETF |